← Back
▼ SELL 10b5-1 Plan

$ Value

$735K

Shares

7,671

Price

$96

Filed

Mar 26

Insider

Name

Balcom Alexandra

Title

Chief Financial Officer

CIK

0001862147

Roles

Officer

Transaction Details

Transaction Date

2026-03-24

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

100,393

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2025. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.34 to $95.33, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) of this Form 4. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.35 to $96.34, inclusive. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.35 to $96.72, inclusive. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.61, inclusive. | The shares underlying this option are fully vested.

Filing Info

Accession No.

0001862147-26-000002

Form Type

4

Issuer CIK

0001861560

Balcom Alexandra's History

Date Ticker Type Value
2026-04-01 NUVL M $12K
2026-04-01 NUVL $370K
2026-04-01 NUVL $570K
2026-04-01 NUVL $262K
2026-04-01 NUVL M $0
2026-03-25 NUVL $1.4M
2026-03-24 NUVL M $12K
2026-03-24 NUVL $247K
2026-03-24 NUVL $735K
2026-03-24 NUVL $112K

Other Insiders at NUVL (90d)

Insider Bought Sold Last
Balcom Alexandra
Chief Financial Officer
$2.9M 2026-04-01
Noci Darlene
Chief Development Officer
$538K 2026-03-30
Porter James Richard
President and CEO
$3.1M 2026-04-06
Miller Deborah Ann
Chief Legal Officer
$543K 2026-03-26
Pelish Henry E.
Chief Scientific Officer
$323K 2026-04-09
Lane Benjamin
See Remarks
2026-04-01